CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 372 enrolled
Drug / intervention
Shed-Meds: A Patient-Centered Deprescribing Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02979353
NCT02979353N/ACompleted

A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy Transferred From the Hospital to Skilled Nursing Facilities

Vanderbilt University Medical Center·interventional·Posted Dec 1, 2016·Updated Jul 19, 2023

In Brief

A clinical study evaluating Shed-Meds: A Patient-Centered Deprescribing Intervention for Polypharmacy and 2 related conditions. Completed, enrolled 372 participants across 1 site.

Detailed Summary

This randomized, controlled trial will evaluate the effects of an intervention to reduce exposure to medications among hospitalized older adults discharged to skilled nursing facilities (SNFs). The goal of the intervention is to safely deprescribe medications, as defined by dose reductions and stopped medications, based on a combination of clinical criteria and patient preferences. The investigators will evaluate the effects of the intervention on the total number of medications prescribed to patients at hospital and SNF discharge and at home 90-days after SNF discharge along with the prevalence of eight geriatric syndromes, medication adherence, and health status.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 1, 2016
Enrollment StartMar 6, 2017
Primary CompletionMay 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 9.6 years ago

Interventions

Shed-Meds: A Patient-Centered Deprescribing Interventionbehavioral

The goal of the intervention is to safely deprescribe medications, as defined by dose reductions and stopped medications, based on a combination of clinical criteria and patient preferences.